Perception shift helps to propel cannabis industry to new heights
The cannabis market has shown investors its long-term potential in recent years.
Despite legal setbacks on the federal level, the young cannabis industry has made impressive...
Asia Pacific: cannabis testing and the untapped CBD market
Cannabis and hemp are generally illegal across the Asia Pacific region however, places such as Thailand have recently legalised medical cannabis.
As attitudes changes towards...
Plans for comprehensive analytical testing review for UK cannabis industry
The Centre for Medicinal Cannabis (CMC) has outlined their plans to undertake a comprehensive review of analytical testing for the cannabis industry.
Recent market research...
CannaBiz Innovation Hub: how to source and ensure quality ingredients
The legal cannabis market is evaluated to be worth in excess of $60bn (~€54.77) by 2025, with the CBD market estimated to hit $20bn...
Ehlers-Danlos and chronic pain added to US Marijuana Programme
Ehlers-Danlos Syndrome and chronic pain have been accepted onto Connecticut Medical Marijuana Programme by the Board of Physicians.
The state’s Medical Marijuana Program’s Board of...
Illinois awards first cannabis cultivation licences and opens new applications
Four companies are the first to be awarded an adult-use cultivation licence from the Illinois Department of Financial and Professional Regulation (IDFPR).
The companies, Ascend...
Medical cannabis use amongst older Canadians increasing
According to research by Oxford University, older adults are the fastest growing demographic of Canadian cannabis users.
The implications, however, of medical cannabis use for older adults...
Cannabis camp will provide cultivation and extraction capabilities
Ikänik Farms is pleased to announce it has received all necessary licenses required to begin construction of its cannabis camp in Adelanto, California.
Ikänik Farms...
American Society of Cannabis Medicine to assess cannabis regulation
The American Society of Cannabis Medicine (ASCM) has announced that members of its leadership have been asked to participate at the Second Annual Update...
The American Food and Drug administration: regulating CBD products
The FDA stands ready to protect consumers from companies illegally selling CBD products that claim to prevent, diagnose, treat, or cure serious diseases, such...
Raphael Mechoulam: father of cannabis research unveils latest findings
The father of medical cannabis research announced a new finding that has the potential for stronger therapeutic effects than CBD.
Raphael Mechoulam headlined the list of...
New Frontier Data releases new 2019 US hemp study
New Frontier Data, the authority in data, analytics and business intelligence for the global cannabis industry, in collaboration with Vote Hemp, releases The US...
Access for patients: Czech Republic confirms medical cannabis subsidies
From the new year the Czech Republic Ministry of Health will be subsidising payment of medical cannabis from public health insurance.
Since 2010 cannabis has...
The Federal Government of Brazil is facilitating the importation of medicinal CBD
A new system tool was announced by the Federal Government to facilitate the importation of medicinal CBD in Brazil, and CBD Vida will be...
Yin and yang: an exploration of the endocannabinoid system
Vital for maintaining health, the endocannabinoid system is found in both animals and humans.
The two cannabinoid receptors, CB1 and CB2, belong to the so-called...
House approves Cannabis SAFE Banking Act in historic vote
For the first time in history, a standalone cannabis policy reform bill was brought before the House of Representatives for a vote and passed...
Colombia the land of opportunity: cannabis licences for sale
Did you know Blue Dream Industries, the cannabis consulting company, has multiple cannabis licences for sale? Could this be the perfect way to connect...
Arthritis Foundation Releases First CBD Guidance for adults with arthritis
The Arthritis Foundation, in partnership with top experts in arthritis pain and CBD, offers patients a practical, first-of-its-kind resource with answers to their most...
First CBD oil to be approved by the European Medicines Agency
A GW Pharmaceuticals Cannabidiol oral solution, EPIDYOLEX®, is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA).
EPIDYOLEX® cannabidiol oral...
Altitude Investment Management invests $5.5 Million in KannaSwiss
Altitude Investment Management announced today a $5.5 (~€5m) million investment in Switzerland-based KannaSwiss as its first European investment.
Earlier this year, Altitude Investment Management plc (AIM plc),...
